Human Epidermal Growth Factor 2 (HER2) in Early Stage Uterine Serous Carcinoma: A Multi-Institutional Cohort Study

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) has emerged as an important prognostic and therapeutic target in advanced stage and recurrent uterine serous carcinoma (USC). The significance of tumoral HER2 expression in early-stage disease has not been established. METHODS: This multi-c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Erickson, Britt K., Najjar, Omar, Damast, Shari, Blakaj, Adriana, Tymon-Rosario, Joan, Shahi, Maryam, Santin, Alessandro, Klein, Molly, Dolan, Michelle, Cimino-Mathews, Ashley, Buza, Natalia, Ferriss, J. Stuart, Stone, Rebecca L., Khalifa, Mahmoud, Fader, Amanda N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541557/
https://ncbi.nlm.nih.gov/pubmed/32709539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.07.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados